Cargando…
Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model
Epoxyeicosatrienoic acids (EET) and related epoxy fatty acids (EpFA) are endogenous anti‐inflammatory compounds, which are converted by the soluble epoxide hydrolase (sEH) to dihydroxylethersatrienoic acids (DHETs) with lessened biological effects. Inhibition of sEH is used as a strategy to increase...
Autores principales: | Trindade‐da‐Silva, Carlos A., Clemente‐Napimoga, Juliana T., Abdalla, Henrique B., Rosa, Sergio Marcolino, Ueira‐Vieira, Carlos, Morisseau, Christophe, Verri, Waldiceu A., Montalli, Victor Angelo Martins, Hammock, Bruce D., Napimoga, Marcelo H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383812/ https://www.ncbi.nlm.nih.gov/pubmed/32400048 http://dx.doi.org/10.1096/fj.202000415R |
Ejemplares similares
-
Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine
por: Wan, Xiayun, et al.
Publicado: (2020) -
The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling
por: Luo, Ailin, et al.
Publicado: (2023) -
Secreted Osteoclastogenic Factor of Activated T Cells (SOFAT) Is Associated With Rheumatoid Arthritis and Joint Pain: Initial Evidences of a New Pathway
por: Napimoga, Marcelo Henrique, et al.
Publicado: (2020) -
Research progress on the protective mechanism of a novel soluble epoxide hydrolase inhibitor TPPU on ischemic stroke
por: Huang, Pan
Publicado: (2023) -
Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)